Back
Tarsus Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
63
TARS
Tarsus Pharmaceuticals
Last Price:
51.15
Seasonality Move:
13.83%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
0.56
Seasonality Move:
-8.54%
Buy
63
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy, Sell or Hold?
- The current Tarsus Pharmaceuticals [TARS] share price is $51.08. The Score for TARS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- TARS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.56. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TARS Stock Price Chart
What is Tarsus Pharmaceuticals's stock price today?
-
The Tarsus Pharmaceuticals share price today is $51.08
The current trend is moderately bullish and TARS is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
TARS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 60.34 | Buy |
| Chaikin Money Flow: | -44648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.69 - 51.23) | Buy |
| Bollinger Bands (100): | (26.8 - 45.46) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 37.85 | Sell |
| Chaikin Money Flow: | 45726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.58 - 0.72) | Sell |
| Bollinger Bands (100): | (0.37 - 0.91) | Sell |
TARS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.09 | Sell |
| 20-day SMA: | 49.23 | Buy |
| 50-day SMA: | 43.98 | Buy |
| 200-day SMA: | 34.45 | Buy |
| 8-day EMA: | 50.96 | Buy |
| 20-day EMA: | 49.38 | Buy |
| 50-day EMA: | 44.69 | Buy |
| 200-day EMA: | 34.71 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.57 | Sell |
| 20-day SMA: | 0.63 | Sell |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 2.02 | Sell |
| 8-day EMA: | 0.58 | Sell |
| 20-day EMA: | 0.61 | Sell |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 4.96 | Sell |
Tarsus Pharmaceuticals Earnings Growth & TARS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $1.55 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Tarsus Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||